InvestorsHub Logo

thewind

02/22/17 9:07 PM

#9881 RE: riaguy #9880

Agreed

The possibility of a patch is what needs to be sold to a large pharma for partnership in development. Continuing to foot the bill with dilution will test patience of the institutions as well as regular "Joe." The slow build up with publications is setting the base on which to sell the product, understood.

Get a salesperson with "it" because from what I have seen on video of company leadership, and heard in conference calls, the ketchup popsicle is not going to the lady in white gloves.